Trial Profile
A Controlled Study of the Safety and Immunogenicity of ChimeriVax Japanese Encephalitis Vaccine in Thai Toddlers and Children
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2017
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary) ; Hepatitis A vaccine inactivated
- Indications Hepatitis A; Japanese encephalitis
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 04 Nov 2016 Results of a 5-year follow-up assessment published in the Vaccine.
- 26 Sep 2016 Results assessing immune response after a long term follow-up upto five years published in the Vaccine.
- 06 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.